TP53 and neoplasm: Several compelling reasons make mutant p53 (mutp53) an appealing target for cancer therapy; in particular, the exceptionally high frequency of p53 mutations in human tumors of diverse types makes p53 unique among genes involved in tumor development [9, 10].